Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (OTC Pink - Current Information:SNYNF)

98.25
Delayed Data
As of Jun 23
 +3.20 / +3.37%
Today’s Change
68.80
Today|||52-Week Range
100.55
+21.67%
Year-to-Date
Good Companies From Warren Buffett's Portfolio
Jun 23 / GuruFocus News - Paid Partner Content
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug
Jun 21 / Zacks.com - Paid Partner Content
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Horizon Pharma Gets Health Canada Approval for Procysbi
Jun 20 / Zacks.com - Paid Partner Content
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
Jun 23 / TheStreet.com - Paid Partner Content
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio
Jun 20 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
Sanofi: Should Value Investors Consider SNY Stock?
Jun 19 / Zacks.com - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close95.05
Today’s open98.25
Day’s range98.25 - 98.25
Volume372
Average volume (3 months)4,868
Market cap$123.8B
Dividend yield3.31%
Data as of 12:16pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+11.31%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-2.33%
P/E ratio--
Price/Sales2.81
Price/Book2.03

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$37.4B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts